Summary of Purpose
To test the hypothesis that ischaemic stroke patients selected with significant penumbral mismatch at 3 - 9 hours post onset of stroke will have improved clinical outcomes when given intravenous tPA compared to placebo.Read More →
The following dates are available for this trial. Trial information last updated on 22 July 2009.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- National Stroke Research Institute (NSRI)
The study will be a randomised, multicentre, double blinded, placebo controlled phase 3 trial (2 arm with 1:1 randomisation) within a larger cohort study of ischaemic stroke patients. Patients randomised to treatment will be stratified for time of randomisation after stroke to within <6 hours and 6-9 hours.
Amanda Gibbins Research Assistant Neuroscience Trials Australia Level 1, Neuroscience Building Heidelberg Repatriation Hospital 300 Waterdale Road Heidelberg Heights, Vic 3081 Australiaagibbins@neurotrialsaustralia.com